Source map — Silicon Valley's longevity drug obsession is facing its first real reality check
Every domain this feed has drawn corroborated signal from. We store facts and short excerpts and link back to originals — never republished article bodies.
| Source | Type | Trust |
|---|---|---|
| TechSpot | news | 60% |
| Deseret News | news | 60% |
| Fast Company | news | 60% |
| VailDaily.com | news | 60% |
| www.thecooldown.com | news | 50% |
| summabase.com | news | 50% |
| longevitynext.com | news | 50% |
| thebeyondtomorrowpodcast.wordpress.com | news | 50% |
| www.rapamycin.news | news | 50% |
| pharmaphorum.com | news | 50% |
| www.modernpeptidescience.com | news | 50% |